ADR News Bulletin 2013 April (Volume 15 Number 1)
Healthcare professional
Industry member
Therapeutic Products
1 April 2013
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Azithromycin and potential risk of QT prolongation
Intramuscular medroxyprogesterone and injection site necrosis and atrophy
AE case in focus: Test yourself
New enhancements to the medical device regulatory framework
Analysis of adverse event reports for Year 2012
Bupropion and possible increased risk of congenital cardiovascular malformations
Reminder on the safer use of NSAIDs
Levothyroxine and potential risk of fractures
Rivaroxaban (Xarelto®) and reports of lack of efficacy in orthopaedic surgery indication
Click on the link below to download the issue in pdf:
